Sorafenib tosylate

CAS number
475207-59-1
Application
Sorafenib tosylate is an inhibitor of Flk-1 (VEGFR), PDGFR and Raf kinases used for the treatment of human hepatocellular carcinoma.
Molecular weight
637.03 g/mol
Molecular formula
C21H16ClF3N4O3•C7H8SO3

SOCOSUR OEL/OEB Risk Assessments are a quick and efficient way to obtain:

  • Complete review of all relevant toxicological and medical databases as well as Material Safety Data Sheets and chemical books, in accordance with the regulations from National Institute for Occupational Safety and Health (NIOSH), Naumann and Safebridge
  • A classification in four categories based on CLP Regulation and Naumann and Safebridge proposals
  • A rational for NOAEL values selection
  • Categorization for the specific work conditions

Benefits of such OEL/OEB Assessment

A 20 to 30 pages report signed by an European toxicological expert, optimized in case of Regulatory Body inspection, with all calculation details and all bibliographic references linked to these calculations, as well as all the development and results for the categorization of the product.